Arterial Hypertension and Cardiovascular Risk Factors in Patients Admitted to Internal Medicine at Donka University Hospital

Abstract

Introduction: The objective of this study was to contribute to a better understanding of high blood pressure (HBP) and other cardiovascular risk factors associated with the internal medicine department of Donka University Hospital. HTA is a public health problem. A cardiovascular risk factor (CVRF) is a factor to which exposure increases the risk of developing cardiovascular disease while removing or improving this factor decreases the risk. Materials and methods: This was a prospective descriptive study lasting 6 months from January 1, 2024 to June 31, 2024. Hypertensive patients with at least one cardiovascular risk factor (FDRCV) in addition to hypertension were included. The epidemiological (sociodemographic), clinical, paraclinical and therapeutic variables of the patients were recorded. Results: Out of a total of 456 patients registered, 180 were hypertensive with at least one cardiovascular risk factor, which is 39.4%. The mean age was 63.68 ± 14.98 years with extremes of 30 and 95 years. The female sex predominated in 53.9% with a sex ratio of 0.8. The socio-professional stratum was dominated by housewives in 40.6%. The most common reasons for consultation were headaches (92.8%), ringing in the ears (79.4%) and visual disturbances (62.8%). The toxic lifestyle was dominated by smoking in 18.3%. On the electrocardiogram (ECG), the anomalies encountered were dominated by left ventricular hypertrophy (LVH) 38.3% and the sequelae of infarction 28.9%. HTA was associated with 2 FDRCV in 33.88% and 3 FDRCV in 37.22%. Conclusion: The concern raised by HTA and cardiovascular risk factor due not only to their lack of awareness but also to their uncontrolled management requires the implementation of prevention and early detection measures for these factors to reduce morbidity and mortality linked to cardiovascular diseases.

Share and Cite:

Sylla, D. , Kake, A. , Bah, M. , Diakhaby, M. , Diop, T. , Kante, M. , Conté, M. and Cissoko, M. (2024) Arterial Hypertension and Cardiovascular Risk Factors in Patients Admitted to Internal Medicine at Donka University Hospital. Open Journal of Internal Medicine, 14, 374-382. doi: 10.4236/ojim.2024.144035.

1. Introduction

According to WHO, HBP is defined as any systolic blood pressure greater than or equal to 140 mmHg and/or diastolic blood pressure greater than or equal to 90 mmHg on two (2) occasions and on different days, it is a chronic pathology which constitutes a real public health and economic problem [1]. The management of high blood pressure remains more relevant than ever since its prevalence is very high 333 million hypertensive patients in industrialized countries, 666 million in emerging countries [2]. The increasing prevalence of hypertension is attributable to population growth, ageing and behavioural risk factors such as poor diet, harmful use of alcohol and tobacco, lack of physical activity, excess weight and exposure to persistent stress [3]. It contributes to the burden of disease from heart disease, stroke and kidney failure and to the occurrence of premature death and disability [4]. Cardiovascular diseases are responsible for approximately 17 million deaths per year worldwide [5]. High-income countries have a lower prevalence of hypertension (35%) and higher in the African Region with a prevalence of 46% in adults aged 25 years and above [6]. In Senegal, Mbaye et al. [7] in 2011 in a survey on cardiovascular risk factors hadreported that the prevalence of hypertension was 46%.

In Guinea, according to the STEPS survey, high blood pressure affects 28.1% of the population surveyed and little data is available on diseases and other cardiovascular risk factors found were overweight and obesity (14.6%), diabetes and moderate fasting hyperglycemia (5.2%), tobacco consumption (15.2%) and alcohol (4.7%) [8].

The resurgence of cardiovascular diseases and CVRF motivated the choice of this study.

2. Materials and Methods

This was a prospective descriptive study lasting 6 months from January 1, 2024 to June 31, 2024. Known hypertensive patients, newly diagnosed patients and patients under treatment with at least one cardiovascular risk factor in addition to hypertension were included. Epidemiological (sociodemographic), clinical, paraclinical and therapeutic variables of the patients were recorded.

We used patient records and data in the Internal Medicine his system to collect data on a survey form established while respecting patient confidentiality. regardless of age, gender, and origin and having agreed to participate in the study.

We recruited all patients with at least one cardiovascular risk factor in addition to hypertension (old or newly diagnosed) during the study period.

To identify risk factors, we used:

  • Patient questioning and consultation of medical records for smoking (number of packs/year = number of wicks per day x number of years divided by 20), alcoholism (daily consumption of at least 5 glasses of alcohol per day for men and 3 glasses for women or more than 30 g/day).

  • We considered sedentary to be all people spending more than 5 hours per day in a sitting or lying position outside of sleep.

  • Body mass index (BMI) to determine and type obesity.

  • Lipid profile to look for dyslipidemia and hypercholesterolemia.

  • Diabetes was retained as FRDCV in patients known to be diabetic but not balanced, glycated hemoglobin greater than 6.5%.

The data were analyzed with Epi-Info software (version 7.3).

We collected the data anonymously after explaining the study objectives to the patients and emphasizing the principle of confidentiality.

3. Results

Total of 456 hospitalized patients, 180 patients had HTA and at least 1 FRCV is 39.4% and 276 patients had other diseases apart from HTA is 60.6% (Figure 1).

There the most dominant age group was 70 - 79 years (45 patients or 25%), followed by 60 - 69 years (38 patients or 21.11%) with a mean age: 63.68 ± 14.98 years and extremes of 30 and 95 years.

The female sex was in the majority: 97 patients or 53.9% against 83 patients or 46.1% with a sex ratio M/F: 0.8.

Table 1. Distribution of patients according to socio-professional groups.

Socio-professional groups

Effective

Percentage

Student

7

3.88

Traders

16

8.88

Housewife

73

40.55

Farmer

24

13.33

Liberal profession

37

20.55

Workers

23

12.77

Total

180

100

Table 2. Distribution of patients according to socio-professional groups.

Socio-professional groups

Effective

Percentage

Student

7

3.88

Traders

16

8.88

House wife

73

40.55

Farmer

24

13.33

Liberal profession

37

20.55

Workers

23

12.77

Total

180

100

Figure 1. Distribution of patients by area of origin.

Table 3. Distribution of patients according to level of education.

Level of education

Effective

Percentage

Superior

32

17.77

Secondary

89

49.44

Primary

36

20

Not in school

23

12.77

Total

180

100

Table 4. Distribution of patients according to reasons for consultation.

Reasons for consultation

Effective

Percentage

Headaches

167

92.77

Visual disturbances

113

62.77

Dizziness

98

54.44

Tinnitus

78

43.33

Ringing in the ears

143

79.4

Tingling fingers

32

17.77

Chest pain

17

9.44

Palpitations

43

23.88

Cough

9

5

Sputum

4

2.2

Dyspnea

17

9.4

Vomiting

5

2.8

Nausea

10

100

Lifestyle, 91 patients with no vices were in the majority, is 50.55%, followed by tobacco consumption (33 patients or 18.33%) and sedentary lifestyle (25 patients or 13.88%).

Table 5. Distribution of patients according to body mass index.

Body mass index

Effective

Percentage

Skinny

11

6.11

Normal

93

51.66

Overweight

37

20.55

Obesity

39

21.66

Total

180

100

Average BMI: 27.07 ± 0.66 kg/m2 Extreme: 17.57 and 36.42 kg/m2.

Table 6. Distribution of patients according to identified FDRCV.

FDRCV identified

Effective

Percentage

HTA

180

100

Age > 55 years

128

71.11

Diabetes

92

51.11

Smoking

49

27.22

Alcoholism

31

17.22

Sedentary lifestyle

25

13.88

Obesity

39

21.66

Table 7. Distribution of patients according to the association between FDRCV.

Association between FDRCV

Effective

Percentage

HTA + 1 FDRCV

31

17.22

HTA + 2 FDRCV

61

33.88

HTA + 3 FDRCV

67

37.22

HTA + 4 FDRCV

17

9.44

HTA + 5 FDRCV

4

2.22

Total

180

100

Table 8. Distribution of patients according to HTA therapy.

HTA therapy

Staff

Percentages

Calcium channel blocker

57

31.66

Angiotensin converting enzyme inhibitor

41

22.77

β-blocker

23

12.77

IEC + IC

98

54.44

IC + β-blocker

17

9.44

4. Discussion

Hypertension is one of the most important modifiable risk factors for cardiovascular diseases (FRDCV) worldwide. During this study period, out of 456 registered patients, we collected 180 cases of hypertension associated with at least one cardiovascular risk factor, is a frequency of 39.4% (Table 7). Bhadoria S et al. [9] in India in 2014 in their review on the prevalence of hypertension and associated cardiovascular risk factors found a prevalence of 17%. Shen Y et al. [10] in China in 2017 reported a prevalence of 28.1%. This low rate of hypertension associated with at least one risk factor could be explained by the fact that the internal medicine department deals with various pathologies and the majority of hypertension cases listed in the emergency room are referred to the cardiology department.

The age group 70 - 79 years was the most found with a mean age of 63.68 ± 14.98 years. Singh S et al. [11] in India in 2017, in their cross-sectional study on the prevalence and risk factors associated with hypertension in Varanasi, had found a mean age of 39.0 ± 11.9 years. Pessinaba S et al. [12] in Senegal in 2013 which reported an age means of 53.6 ± 15.9 years. These results obtained are in agreement with the data of the literature according to which with age, the walls of the aorta and arteries stiffen, which contributes to the high prevalence of hypertension in older groups. Age is a risk factor of a particular nature, since it is correlated with the duration during which an individual is exposed to other risk factors. It therefore reflects the effect of prolonged exposure to risk factors and is correlated with the occurrence on communicable diseases (MNT).

In our study, we reported a female predominance (53.9%) with a sex ratio of 0.8. Yayehd K et al. [13] in Togo in 2011 had found 53.3% female predominance respectively. This female predominance in our study is in agreement with the data in the literature. Also, this female predominance could be explained by the multifactorial association in women, in particular obesity, sedentary lifestyle, taking contraception but also by the loss of the beneficial effect of sex hormones on the regulation of HBP for postmenopausal women.

Regarding the socio-professional stratum, housewives (40.6%) were representative in our study (Table 1, Table 2). Kishore J et al. [14] in India in 2016 who reported that the representative stratum was retirees in 47.1%. Hien A et al. [15] in Vietnam in 2018 also reported that manual workers were the most representative stratum in 44.8%. In our context, the low socio-cultural level that characterizes this stratum could explain their greater exposure and who only consult after the onset and persistence of clinical signs related to HBP or in the event of proven cardiovascular diseases (Table 3, Table 4).

In our case, the lifestyle assessment in our hypertensive patients had highlighted 18.33% of smokers. Brazzaville Gombet TH et al. [16] in 2011 had also reported 11.8% and 3.4% of diabetes and smoking associated with HBP in their series. Arambam P et al. [17] in India in 2022 in a study on uncontrolled HBP had reported that tobacco consumption was observed in 25% of the population.

According to WHO, smoking is one of the major risk factors for cardiovascular diseases, Active and passive smoking damages the heart and blood vessels, although the pathological mechanisms may differ depending on the type of action. In addition, changes in blood pressure, regardless of the responsible cause, strongly influence cardiovascular function and structure.

Body mass index assessment in this study revealed subjects with normal BMI in more than half of the cases and obesity in 21.7% with a mean BMI of 27.07 ± 0.66 kg/m2 (Table 5). In the series of Ardiana S et al. [18] in Indonesia in 2023 onthe impact of classic cardiovascular risk factors on hospitalization and mortality, increased BMI was also common, with 19.3% of overweight subjects and 50.1% of subjects diagnosed as obese. This obesity rate in our study could be explained by the predominance of the socio-professional stratum represented by housewives who are subject to physical inactivity in their daily lives (Table 5, Table 6). Furthermore, urbanization is also a cause of changes in eating habits and reduced physical activity that leads to obesity and then results in hypertension [19]. Also, a WHO study revealed that there is a direct link between physical inactivity and weight gain which in turn increases the risk of hypertension.

On the ECG, left ventricular hypertrophy (38.33%) and sequelae of infarction (28.88%) were the main abnormalities detected. Sarr et al. [20] in Senegal in 2016 in their study on the clinical, electrocardiographic and echocardiographic aspects of hypertensive patients found LVH in 28.8% of cases. Our result could be explained initially by the diagnostic delay of HTA in our context but also by the non-compliance with treatment by patients, both of which are factors promoting increased cardiac activity, itself a source of the long-term occurrence of LVH.

The predominance of HBP as the main cardiovascular risk factor in our study is different from that found by Mashael et al. [21] in Saudi Arabia in 2016 reported physical inactivity that ranged from 53.2 to 98.1%. Calas et al. [22] in France in 2022 in their review on the prevalence of hypertension, awareness, treatment and control found that 69% of cases were inactive.

In our study, on the180 patients with high blood pressure (HBP) and at least one (1) cardiovascular risk factor (FRDCV), we reported that HTA + 3 FDRCV in 67 cases or 37.22%, followed by HTA + 2 FDRCV in 61 cases or 33.88%. He F et al. [23] in China in 2023 reported in their study on the prevalence and clustering of cardiovascular risk factors among coastal residents, 82.2% of participants had one or more FDRCV and 45.3% had two or more (Table 7, Table 8).

Indeed, many studies have indicated that the incidence of cardiovascular diseases would be related to the clustering of cardiovascular risk factors and that this clustering of FRDCV has a more harmful cardiovascular effect [24].

From a therapeutic point of view, dual therapy was the most prescribed modality to patients (ACE inhibitors + IC in 54.4%). This result corroborates with that of Arambam P et al. [17] in India in 2022 which reported that Two or more drugs were prescribed in 30.8% of patients. The association of one or more cardiovascular risk factor in our context could explain this therapeutic pattern of use. Furthermore, research conducted in several countries has consistently shown that treatment of risk factors such as hypertension has a higher impact on cardiovascular disease than treatment of established cardiovascular disease [25].

5. Conclusion

The concern raised by HTA and cardiovascular risk factor due not only to their lack of awareness but also to their uncontrolled management requires the implementation of prevention and early detection measures for these factors to reduce morbidity and mortality linked to cardiovascular diseases.

Conflicts of Interest

The authors declare no conflicts of interest regarding the publication of this paper.

References

[1] World Health Organization (2023) World Health Report: Evidence Base.
[2] Sabouret, P. (2006) The Prisma Study: The Problem of High Blood Pressure. Salpêtrière Hospital, 19.
[3] World Health Organization (2011) Global Status Report on Noncommunicable Diseases 2010.
[4] Aubry, P. (2024) Heart Diseases in the Tropics. Institute of Tropical Medicine, 1-12.
[5] World Health Organization (2008) Global Health Observatory Database.
[6] WHO-Guinea (2010) Noncommunicable Diseases: Results of the STEPS Survey, Bimonthly Bulletin of the WHO Representation in Guinea 2010, 18.
[7] Mbaye, M., Niang, K., Sarr, A., Mbaye, A., Diedhiou, D., Ndao, M., et al. (2011) Aspects épidémiologiques du diabète au Sénégal: Résultats d’une enquête sur les facteurs de risque cardiovasculaire dans la ville de Saint-Louis. Médecine des Maladies Métaboliques, 5, 659-664.
https://doi.org/10.1016/s1957-2557(11)70343-1
[8] WHO (2009) Guinea (Conakry and Lower Guinea) STEPS 2009 Survey. The WHO “STEPwise” Approach to Chronic Disease Risk Factor Surveillance. 1-2.
https://www.who.int/chp/steps
[9] Bhadoria, A., Kasar, P., Toppo, N., Bhadoria, P., Pradhan, S. and Kabirpanthi, V. (2014) Prevalence of Hypertension and Associated Cardiovascular Risk Factors in Central India. Journal of Family and Community Medicine, 21, 29-38.
https://doi.org/10.4103/2230-8229.128775
[10] Shen, Y., Chang, C., Zhang, J., Jiang, Y., Ni, B. and Wang, Y. (2017) Prevalence and Risk Factors Associated with Hypertension and Prehypertension in a Working Population at High Altitude in China: A Cross-Sectional Study. Environmental Health and Preventive Medicine, 22, Article No. 19.
https://doi.org/10.1186/s12199-017-0634-7
[11] Singh, S., Shankar, R. and Singh, G.P. (2017) Prevalence and Associated Risk Factors of Hypertension: A Cross-Sectional Study in Urban Varanasi. International Journal of Hypertension, 2017, Article ID: 5491838.
https://doi.org/10.1155/2017/5491838
[12] Pessinaba, S., Mbaye, A., Yabeta, G.A.D., Harouna, H., Sib, A.E., Kane, A.D., et al. (2013) Prevalence Survey of Cardiovascular Risk Factors in the General Population in Saint-Louis (Senegal). Annals of Cardiology and Angiology, 62, 253-258.
[13] Yayehd, K., Damorou, F., Akakpo, R., Tchérou, T., N’Da, N.W., Pessinaba, S., et al. (2013) Prévalence de l’hypertension artérielle et description de ses facteurs de risque à Lomé (Togo): Résultats d’un dépistage réalisé dans la population générale en mai 2011. Annales de Cardiologie et d'Angéiologie, 62, 43-50.
https://doi.org/10.1016/j.ancard.2012.09.006
[14] Kishore, J., Gupta, N., Kohli, C. and Kumar, N. (2016) Prevalence of Hypertension and Determination of Its Risk Factors in Rural Delhi. International Journal of Hypertension, 2016, Article ID: 7962595.
https://doi.org/10.1155/2016/7962595
[15] Hien, H.A., Tam, N.M., Tam, V., Derese, A. and Devroey, D. (2018) Prevalence, Awareness, Treatment, and Control of Hypertension and Its Risk Factors in (Central) Vietnam. International Journal of Hypertension, 2018, Article ID: 6326984.
https://doi.org/10.1155/2018/6326984
[16] Gombet, T.H., Kimbally-Kaky, G., Ikama, M.S. and Ellenga-Mbolla, B.F. (2007) High Blood Pressure and Other Cardiovascular Risk Factors in the Brazzaville Professional Environment. Médecine dAfrique Noire, 54, 545-548.
[17] Arambam, P., Khashoo, R., Tewari, D., Saleem, Z., Shekhawat, S. and Kaul, U. (2022) Uncontrolled Hypertension in a Rural Population of Jammu and Kashmir. Indian Heart Journal, 74, 484-487.
https://doi.org/10.1016/j.ihj.2022.11.012
[18] Julius, S. (2002) The Association of Tachycardia with Obesity and Elevated Blood Pressure. The Journal of Pediatrics, 140, 643-645.
https://doi.org/10.1067/mpd.2002.125519
[19] Oliveras, A. and de la Sierra, A. (2013) Resistant Hypertension: Patient Characteristics, Risk Factors, Co-Morbidities and Outcomes. Journal of Human Hypertension, 28, 213-217.
https://doi.org/10.1038/jhh.2013.77
[20] Sarr, S.A., Babaka, K., Mboup, M.C., Fall, P.D., Dia, K., Bodian, M., et al. (2016) Aspects cliniques, électrocardiographiques et échocardiographiques de l’hypertendu âgé au Sénégal. Pan African Medical Journal, 25, Article 77.
https://doi.org/10.11604/pamj.2016.25.77.10086
[21] Alshaikh, M.K., Filippidis, F.T., Baldove, J.P., Majeed, A. and Rawaf, S. (2016) Women in Saudi Arabia and the Prevalence of Cardiovascular Risk Factors: A Systematic Review. Journal of Environmental and Public Health, 2016, Article ID: 7479357.
https://doi.org/10.1155/2016/7479357
[22] Calas, L., Subiros, M., Ruello, M., Hassani, Y., Gabet, A., Angue, M., et al. (2022) Hypertension Prevalence, Awareness, Treatment and Control in 2019 in the Adult Population of Mayotte. European Journal of Public Health, 32, 408-414.
https://doi.org/10.1093/eurpub/ckac015
[23] He, F., Liao, Z., Li, Y., Luo, Y., Wu, L., Lin, L., et al. (2023) Prevalence and Clustering of Cardiovascular Risk Factors among Resident of Coastal Areas in Qinzhou, Guangxi, China. Journal of Cardiothoracic Surgery, 18, Article No. 70.
https://doi.org/10.1186/s13019-023-02137-0
[24] Thomas, G.N., Schooling, C.M., McGhee, S.M., Ho, S., Cheung, B.M.Y., Wat, N.M.S., et al. (2007) Metabolic Syndrome Increases All‐cause and Vascular Mortality: The Hong Kong Cardiovascular Risk Factor Study. Clinical Endocrinology, 66, 666-671.
https://doi.org/10.1111/j.1365-2265.2007.02798.x
[25] Sekhri, T., Kanwar, R.S., Wilfred, R., Chugh, P., Chhillar, M., Aggarwal, R., et al. (2014) Prevalence of Risk Factors for Coronary Artery Disease in an Urban Indian Population. BMJ Open, 4, e005346.
https://doi.org/10.1136/bmjopen-2014-005346

Copyright © 2025 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.